INSL4 Antikörper (AA 30-139)
-
- Target Alle INSL4 Antikörper anzeigen
- INSL4 (Insulin-Like 4 (Placenta) (INSL4))
-
Bindungsspezifität
- AA 30-139
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser INSL4 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Early placenta insulin-like peptide protein (30-139AA)
- Isotyp
- IgG
- Top Product
- Discover our top product INSL4 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- INSL4 (Insulin-Like 4 (Placenta) (INSL4))
- Andere Bezeichnung
- INSL4 (INSL4 Produkte)
- Synonyme
- EPIL antikoerper, PLACENTIN antikoerper, insulin like 4 antikoerper, INSL4 antikoerper
- Hintergrund
-
Background: May play an important role in trophoblast development and in the regulation of bone formation.
Aliases: early placenta insulin like peptide (EPIL) antibody, Early placenta insulin like peptide A chain antibody, Early placenta insulin like peptide antibody, Early placenta insulin like peptide B chain antibody, Early placenta insulin-like peptide A chain antibody, EPIL antibody, INSL4 antibody, INSL4_HUMAN antibody, insulin like 4 antibody, insulin like 4 (placenta) antibody, Insulin like peptide 4 antibody, Insulin-like peptide 4 antibody, OTTHUMP00000021025 antibody, Placentin antibody
- UniProt
- Q14641
-